The following video is part of a special series in which Motley Fool analyst Andrew Tonner and "Options Whiz" Jeff Fischer discuss how to make 2012 the year YOU master the market. In today's edition, Jeff explains a way to profit off Gilead Sciences that you may not have considered.

Jeff Fischer and Andrew Tonner own no shares of the companies listed above. The Motley Fool owns shares of Abbott Laboratories. Motley Fool newsletter services have recommended buying shares of Gilead Sciences, Pfizer, and Abbott Laboratories. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.